**********NEW SPEAKER ADDED***************
In partnership with McDermott Will & Emery LLP

Program Overview:
Raising money in today's environment is no easy task - but it can be done if you focus on the right priorities and avoid common deal-killers. In this half-day workshop, Peter Townshend from McDermott Will & Emery LLP and Kim Kamdar from Domain Associates will provide you with actionable advice that will prepare you for raising capital from venture capital funds.

Benefits of Attending:
-Understanding venture funds and how they operate;
-Identifying best practices for obtaining a term sheet;
-Understanding the stages of a venture capital financing; and
-Learning common terms used in such transactions and what they mean.

Who should attend:
Founders, CEOs, and managers who are seeking venture funding, as well as scientists and technology experts considering a business start-up in need of venture financing. Please no competing attorneys.

About the Presenters:
Peter N. Townshend, partner at McDermott Will & Emery LLP, is a recognized expert on issues relating to technology start-up companies and venture capital. He has lectured at U.C. Berkeley, U.C. San Diego, Santa Clara University, and San Jose State University, and has been quoted in the Silicon Valley/San Jose Business Journal, the San Francisco Chronicle, TheDeal.com, Entrepreneur Magazine, Washington Post, and Reuters. He is a regular lecturer on topics relating to technology start-up companies, angel and venture capital, and technology start-up company mergers and acquisitions.

Kim P. Kamdar, Ph.D., Principal, Domain Associates, LLC.
Ms. Kamdar joined Domain Associates in 2005 and became a Principal in 2006. Present board memberships include Nuon Therapeutics, Obalon Therapeutics, ROX Medical, Sonexa Therapeutics, Syndax Pharmaceuticals, Tragara Pharmaceuticals, as well as observer status at Achaogen, BiPar Sciences, Corthera, GenVault, Lipothera and SkinMedica. Ms. Kamdar serves as an advisory board member to Eric Topol’s NIH supported Clinical and Translational Science Award for Scripps Medicine. Additionally, Ms. Kamdar serves as an Advisory Board Member for Evolvence India Life Sciences Fund, a private equity fund providing growth capital to Indian pharmaceutical and biotechnology companies. From 2003-2004, Ms. Kamdar was a Kauffman Fellow with MPM Capital. Prior to joining MPM, Ms. Kamdar was a Research Director at Novartis. She built and led a research team that focused on the biology, genetics and genomics of model organisms to uncover small molecules that modulated signaling pathway networks. Ms. Kamdar is a founder of Aryzun Pharmaceuticals, a biotech company utilizing protein-protein interaction mapping for small molecule discovery with an initial focus on anti-infectives and oncology. Ms. Kamdar is the author of ten papers as well as the inventor on seven patents.

Date: March 2, 2010
Time: 8:30 a.m. - 12:00 a.m. (Registration begins 8:00 a.m.)
Location: Sanford - Burnham Institute (formerly SKCC)
10905 Road to the Cure
San Diego, CA 92121
Note: A light breakfast will be provided for participants.
Contact: Linda Wells
Email: lmwells@connect.org
Phone: 858-964-1319
Fees: Pre-Registration $45.
At the Door $65.
*Note- Registration will close at 4pm on March 1. Walk-in registration will be available.
Register Here
**********NEW SPEAKER ADDED***************